Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check3 days agoChange DetectedRevision tag on the Record History page was updated from v3.6.0 to v3.6.2, signaling a minor version update of the page itself. This change reflects an administrative update rather than a modification to the study data or user-facing content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe history adds 'No longer looking for participants' and 'Revision: v3.6.0', and removes the older 'Revision: v3.5.5'.SummaryDifference0.4%

- Check25 days agoChange DetectedA new revision label v3.5.5 is added to the record history, replacing the previous v3.5.4 label to reflect a page update.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the Record History, and the previous 'Revision: v3.5.3' entry was removed from the list.SummaryDifference0.1%

- Check67 days agoChange DetectedA minor interface/software revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the page’s release/versioning rather than any study-record details.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.